Serum Magnesium Levels in Children With and Without Migraine: A Cross-Sectional Study

Rishab Bhurat1, Sarala Premkumar2, Ranjith Kumar Manokaran3

  • 1Department of Pediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu.

Indian Pediatrics
|June 25, 2022
PubMed

Insights

Low serum magnesium levels are linked to migraine in adolescents. This finding suggests potential new treatment strategies for pediatric migraine headaches.

Area of Science:

  • Pediatric Neurology
  • Clinical Biochemistry

Background:

  • Migraine is a common neurological disorder in children.
  • Serum magnesium levels have been investigated as a potential factor in migraine pathophysiology.

Purpose of the Study:

  • To investigate the association between serum magnesium levels and migraine in children.
  • To determine if magnesium deficiency is a risk factor for pediatric migraine.

Main Methods:

  • Cross-sectional study design.
  • Inclusion of children aged 5-18 years diagnosed with migraine and age-/sex-matched controls.
  • Diagnosis of migraine based on International Classification of Headache Disorders 3 (ICHD-3) criteria.

Main Results:

  • Overall, serum magnesium levels were comparable between children with migraine and controls.
  • A statistically significant finding revealed lower serum magnesium levels in the adolescent subgroup with migraine compared to controls.
  • Median serum magnesium levels were 2.0 (IQR 1.9-2.1) mg/dL in adolescent migraineurs versus 2.2 (IQR 2.0-2.2) mg/dL in controls (P<0.045).

Conclusions:

  • Low serum magnesium levels are significantly associated with migraine occurrence in adolescents.
  • These findings suggest that magnesium deficiency may play a role in adolescent migraine.
  • The results may have implications for the treatment and management of migraine in pediatric populations.
Abstract

Related Concept Videos